Trial Outcomes & Findings for Newborn Ventilation in the Delivery Room: Could it be Improved With a T-piece Resuscitator? (NCT NCT00443118)

NCT ID: NCT00443118

Last Updated: 2018-09-28

Results Overview

Recruitment status

COMPLETED

Study phase

PHASE3

Target enrollment

1032 participants

Primary outcome timeframe

2 minutes of life

Results posted on

2018-09-28

Participant Flow

Participant milestones

Participant milestones
Measure
T-Piece
Subjects assigned to be resuscitated with T-Piece
SIB - With PEEP Valve
Subjects allocated to SIB with a PEEP valve attached
SIB-Without PEEP Valve
Self inflating bag without PEEP valve
Overall Study
STARTED
515
291
226
Overall Study
COMPLETED
511
290
226
Overall Study
NOT COMPLETED
4
1
0

Reasons for withdrawal

Reasons for withdrawal
Measure
T-Piece
Subjects assigned to be resuscitated with T-Piece
SIB - With PEEP Valve
Subjects allocated to SIB with a PEEP valve attached
SIB-Without PEEP Valve
Self inflating bag without PEEP valve
Overall Study
unknown primary outcome
3
1
0
Overall Study
Withdrawal by Subject
1
0
0

Baseline Characteristics

Newborn Ventilation in the Delivery Room: Could it be Improved With a T-piece Resuscitator?

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
Self Inflating Bag With PEEP
n=290 Participants
Subjects allocated to Self Inflating Bag with PEEP
Self Inflating Bag Without PEEP
n=226 Participants
Subjects allocated to Self Inflating Bag without PEEP
Total
n=1027 Participants
Total of all reporting groups
Age, Continuous
36 weeks
STANDARD_DEVIATION 4.1 • n=5 Participants
35 weeks
STANDARD_DEVIATION 5 • n=7 Participants
37 weeks
STANDARD_DEVIATION 4 • n=5 Participants
36 weeks
STANDARD_DEVIATION 4.2 • n=4 Participants
Sex: Female, Male
Female
208 Participants
n=5 Participants
117 Participants
n=7 Participants
101 Participants
n=5 Participants
426 Participants
n=4 Participants
Sex: Female, Male
Male
303 Participants
n=5 Participants
173 Participants
n=7 Participants
125 Participants
n=5 Participants
601 Participants
n=4 Participants
previous deliveries
primiparous
220 number of participants
n=5 Participants
137 number of participants
n=7 Participants
106 number of participants
n=5 Participants
463 number of participants
n=4 Participants
previous deliveries
multiparous
291 number of participants
n=5 Participants
153 number of participants
n=7 Participants
120 number of participants
n=5 Participants
564 number of participants
n=4 Participants
ANTENATAL STEROIDS
YES
142 participants
n=5 Participants
84 participants
n=7 Participants
72 participants
n=5 Participants
298 participants
n=4 Participants
ANTENATAL STEROIDS
NO
369 participants
n=5 Participants
206 participants
n=7 Participants
154 participants
n=5 Participants
729 participants
n=4 Participants

PRIMARY outcome

Timeframe: 2 minutes of life

Population: The analysis was performed by intention to treat

Outcome measures

Outcome measures
Measure
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
Proportion of Infants With a HR ≥ 100 Bpm at 2 Minutes of Life.
93.7 percentage of participants
88 percentage of participants
93 percentage of participants

SECONDARY outcome

Timeframe: 2 minutes of life

Outcome measures

Outcome measures
Measure
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
Time the Newborn Takes to Reach a HR > 100 Bpm
1 minutes
Interval 0.5 to 1.6
1 minutes
Interval 0.5 to 1.8
1 minutes
Interval 0.5 to 1.9

SECONDARY outcome

Timeframe: 2 minutes of life

Population: the pulse-oximeter was reliable at 2 minutes in 69% of the cases in both groups.

Outcome measures

Outcome measures
Measure
T-Piece
n=350 Participants
Subjects assigned to be resuscitated with T-Piece
SIB - Self Inflating Bag With PEEP Valve
n=199 Participants
Subjects allocated to SIB with PEEP valve attached
SIB-Without PEEP Valve
n=155 Participants
Subjects allocated to SIB-Without PEEP valve attached
• SpO2 Value at 2 Minutes of Life.
82 percentage of oxygen saturation
Standard Deviation 14
80 percentage of oxygen saturation
Standard Deviation 20
77 percentage of oxygen saturation
Standard Deviation 16

SECONDARY outcome

Timeframe: after 2 minutes of life

Outcome measures

Outcome measures
Measure
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
• Proportion of Eligible Newborns Who Entered the Study and Who Were Intubated After Failure of PPV With Mask.
17 percentage of participants
28 percentage of participants
23 percentage of participants

SECONDARY outcome

Timeframe: after 2 minutes of life

Outcome measures

Outcome measures
Measure
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
• Need for Chest Compression and/or Medications
8 participants
11 participants
6 participants

SECONDARY outcome

Timeframe: 1-5 minutes of life

categorized Apgar score 1 min \<=3 and categorized Apgar score 5 min \<=5 The Apgar score is applied routinely by nurses and neonatologists to describe how vigorous the baby is at birth, it ranges from 0 to 10, with higher scores representing better outcomes.

Outcome measures

Outcome measures
Measure
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
Apgar Scores at 1 and 5 Minutes
apgar score 1 min <=3
153 participants
111 participants
66 participants
Apgar Scores at 1 and 5 Minutes
apgar score 5 min <=5
30 participants
24 participants
23 participants

SECONDARY outcome

Timeframe: first week of life

Outcome measures

Outcome measures
Measure
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
• Incidence of Neonatal Encephalopathy During First Week of Life (Classified by Sarnat)
21 participants
21 participants
7 participants

SECONDARY outcome

Timeframe: after birth and during hospitalization up to four weeks

included pneumothorax and Pneumomediastinum

Outcome measures

Outcome measures
Measure
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
• Incidence of Air Leaks
13 participants
6 participants
2 participants

SECONDARY outcome

Timeframe: during hospitalization

Outcome measures

Outcome measures
Measure
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
• Use of Oxygen Treatment Beyond the Delivery Room
208 participants/
126 participants/
96 participants/

SECONDARY outcome

Timeframe: after birth and during hospitalization up to four weeks

Outcome measures

Outcome measures
Measure
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
Days on Oxygen
13.8 days
Standard Deviation 17
23 days
Standard Deviation 27
23 days
Standard Deviation 22

SECONDARY outcome

Timeframe: during hospitalization

Outcome measures

Outcome measures
Measure
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
• Need for Mechanical Ventilation or CPAP
116 participants
104 participants
43 participants

SECONDARY outcome

Timeframe: after delivery and before four weeks

Outcome measures

Outcome measures
Measure
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
Days on Mechanical Ventilation
5.0 days
Standard Deviation 7.6
7 days
Standard Deviation 11
12 days
Standard Deviation 17

SECONDARY outcome

Timeframe: after birth and during hospitalization up to four weeks

Outcome measures

Outcome measures
Measure
T-Piece
n=511 Participants
Subjects assigned to be resuscitated with T-Piece
SIB - Self Inflating Bag With PEEP Valve
n=290 Participants
Subjects allocated to SIB with PEEP valve attached
SIB-Without PEEP Valve
n=226 Participants
Subjects allocated to SIB-Without PEEP valve attached
Days on CPAP
7.83 days
Standard Deviation 11.3
9.6 days
Standard Deviation 11.5
5.2 days
Standard Deviation 6.5

SECONDARY outcome

Timeframe: 1 day of life and 30 days after birth

Population: this is an analyisis among the subgroup of subjects \<32 weeks GA. this is the population at risk of this outcome. It extremely unusual intracranial hemorrhage over 32 weeks GA.

Incidence of intracranial hemorrhage grades 3-4 for preterm newborns \<32 weeks by ultrasound evaluation

Outcome measures

Outcome measures
Measure
T-Piece
n=90 Participants
Subjects assigned to be resuscitated with T-Piece
SIB - Self Inflating Bag With PEEP Valve
n=73 Participants
Subjects allocated to SIB with PEEP valve attached
SIB-Without PEEP Valve
n=34 Participants
Subjects allocated to SIB-Without PEEP valve attached
• Incidence of Intracranial Hemorrhage Grades 3-4 for Preterm Newborns <32 Weeks
10 Participants
1 Participants
3 Participants

Adverse Events

T-Piece

Serious events: 11 serious events
Other events: 21 other events
Deaths: 0 deaths

SIB - Self Inflating Bag With PEEP

Serious events: 8 serious events
Other events: 25 other events
Deaths: 0 deaths

SIB Without PEEP

Serious events: 7 serious events
Other events: 19 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
T-Piece
n=511 participants at risk
Subjects assigned to be resuscitated with T-Piece
SIB - Self Inflating Bag With PEEP
n=290 participants at risk
Subjects allocated to be ventilated with Self Inflating Bag with PEEP valve
SIB Without PEEP
n=226 participants at risk
Subjects allocated to be ventilated with Self Inflating Bag without PEEP valve
General disorders
mortality
2.2%
11/511 • Number of events 11
2.8%
8/290 • Number of events 8
3.1%
7/226 • Number of events 7

Other adverse events

Other adverse events
Measure
T-Piece
n=511 participants at risk
Subjects assigned to be resuscitated with T-Piece
SIB - Self Inflating Bag With PEEP
n=290 participants at risk
Subjects allocated to be ventilated with Self Inflating Bag with PEEP valve
SIB Without PEEP
n=226 participants at risk
Subjects allocated to be ventilated with Self Inflating Bag without PEEP valve
Respiratory, thoracic and mediastinal disorders
bronchopulmonary dysplasia
4.1%
21/511 • Number of events 21
8.6%
25/290 • Number of events 25
8.4%
19/226 • Number of events 19

Additional Information

Edgardo Szyld MD, MSc

FUNDASAMIN-Fundacion para la Salud Materno Infantil

Phone: 5491144093095

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place